(Q41033561)

25 September 2017

1 reference

title

Significance of the anti-Ro (SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease (English)

1 reference

25 September 2017

1 reference

Provost TT

1

1 reference

25 September 2017

Watson R

series ordinal

2

1 reference

25 September 2017

Simmons-O'Brien E

series ordinal

3

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 August 1996

1 reference

Journal of the American Academy of Dermatology

25 September 2017

published in

1 reference

25 September 2017

volume

35

1 reference

25 September 2017

issue

2 Pt 1

1 reference

25 September 2017

page(s)

147-69; quiz 170-2

1 reference

Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen

25 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Antibodies to cellular antigens in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and sjögren's syndrome: An interlaboratory collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Precipitating autoantibodies in Sjogren's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Precipitating auto-antibodies in the connective tissue diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

LUPUS ERYTHEMATOSUS AND ERYTHEMA MULTIFORME-LIKE LESIONS. A SYNDROME WITH CHARACTERISTIC IMMUNOLOGICAL ABNORMALITIES.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Antibodies to cytoplasmic antigens in lupus erythematosus. Serologic marker for systemic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Lupus band test in untreated SLE patients: correlation of immunoglobulin deposition in the skin of the extensor forearm with clinical renal disease and serological abnormalities.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute Cutaneous Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Serological findings in patients with "ANA-negative" systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Antinuclear antibody determinations in Ro(SSA)-positive, antinuclear antibody--negative lupus and Sjögren's syndrome patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

One hundred anti-Ro (SS-A) antibody positive patients: a 10-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Detection of anti-Ro(SSA) antibodies by gel double diffusion and a 'sandwich' ELISA in systemic and subacute cutaneous lupus erythematosus and Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Isolation and characterization of a cDNA clone encoding the 60-kD component of the human SS-A/Ro ribonucleoprotein autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Human Ro ribonucleoprotein particles: characterization of native structure and stable association with the La polypeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The RNA binding protein La influences both the accuracy and the efficiency of RNA polymerase III transcription in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Function of the mammalian La protein: evidence for its action in transcription termination by RNA polymerase III

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Molecular cloning, expression, and chromosome 19 localization of a human Ro/SS-A autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Dissociation of immune responses to the SS-A (Ro) 52-kd and 60-kd polypeptides in systemic lupus erythematosus and Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Molecular definition and sequence motifs of the 52-kD component of human SS-A/Ro autoantigen

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Protein heterogeneity in the human Ro/SSA ribonucleoproteins. The 52- and 60-kD Ro/SSA autoantigens are encoded by separate genes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Autoantibodies to the Ro/SSA autoantigen are conformation dependent. II: Antibodies to the denatured form of 52 kD Ro/SSA are a cross reacting subset of antibodies to the native 60 kD Ro/SSA molecule

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Anti-Ro/SS-A antibodies in the pathophysiology of congenital heart block in neonatal lupus syndrome, an experimental model. In vitro electrophysiologic and immunocytochemical studies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Sera from patients with autoimmune disease recognize conformational determinants on the 60-kd ro/ss-a protein

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Primary biliary cirrhosis associated with Sjögren's syndrome: evidence for circulating and tissue-deposited Ro/anti-Ro immune complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Homozygous C2 deficiency, lupus erythematosus, and anti-Ro (SSA) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Systemic lupus erythematosus in hereditary deficiency of the fourth component of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The relationship between anti-Ro (SS-A) antibody-positive Sjögren's syndrome and anti-Ro (SS-A) antibody-positive lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Higher incidences of anti-SS-A/Ro and anti-SS-B/La autoantibodies in Japanese patients with autoimmune disorders--studies of antigens and antibodies using the immunoblotting method

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A/Ro) antibodies in female blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Maternal and fetal outcome in neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Serologic studies in patients with lupus erythematosus and psoriasis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus during psoralen ultraviolet A therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The prevalence of antinuclear antibodies in patients with apparent polymorphic light eruption

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus-immunogenetic associations.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Rash in systemic lupus erythematosus: prevalence and relation to cutaneous and non-cutaneous disease manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Systemic lupus erythematosus: a report of forty-five cases with unusual clinical and immunological features

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus: a decade's perspective.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The autoantibody response to Ro/SSA in cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Anti-Ro(SSA) positive rheumatoid arthritis (RA): a clinicoserological group of patients with high incidence of D-penicillamine side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Concurrence of subacute cutaneous lupus erythematosus and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Sjögren's syndrome: association of anti-Ro(SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The Ro/SSA autoantigen as an immunogen. Some anti-Ro/SSA antibody binds IgG.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Immunologic factors and clinical activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Deposition of antibodies to a soluble cytoplasmic antigen in the kidneys of patients with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

In vitro demonstration of a particular affinity of glomerular basement membrane and collagen for DNA. A possible basis for a local formation of DNA-anti-DNA complexes in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Pulmonary manifestations of Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Pulmonary function in patients with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Lung involvement in Sjögren's syndrome: a comparison between patients with primary and with secondary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Purpura hyperglobulinemia of Waldenström; report of a case and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Benign hypergammaglobulinemic purpura of Waldenström

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Unusual cutaneous manifestations of systemic lupus erythematosus: I. Urticaria-like lesions. Correlation with clinical and serological abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Cutaneous Manifestations of Primary Sjögren's Syndrome: A Reflection of Vasculitis and Association with Anti-RO(SSA) Antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Peripheral inflammatory vascular disease in Sjögren's syndrome. Association with nervous system complications

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Necrotizing arteritis and spinal subarachnoid hemorrhage in Sjögren syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The neuropathy of Sjögren's syndrome. Trigeminal nerve involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Sjogren syndrome: Central nervous system manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Aseptic meningoencephalitis in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Primary Sjögren's syndrome with central nervous system disease mimicking multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Anti-Ro(SS-A) autoantibodies in central nervous system disease associated with Sjögren's syndrome (CNS-SS): clinical, neuroimaging, and angiographic correlates

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Neuropsychiatric dysfunction in primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute sensory neuronopathy secondary to dorsal root ganglionitis in primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Polymorphous meningitis with atypical mononuclear cells in Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Primary Sjögren's syndrome with diffuse cerebral vasculitis and lymphocytic interstitial pneumonitis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Cerebral vasculopathy associated with collateralization resembling moya moya phenomenon and with anti-Ro/SS-A and anti-La/SS-B antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The treatable dementia of Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Primary Sjögren's syndrome associated with systemic necrotizing vasculitis: a fatal case

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Neonatal lupus erythematosus with persistent telangiectasia and spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Myelopathy in neonatal and infantile lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The prevalence of primary Sjögren's syndrome in a multiple sclerosis population

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The spectrum of neurological involvement in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Sjögren's syndrome: a study of its neurological complications.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Nervous system manifestations in Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Prevalence of primary Sjögren's syndrome in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Cognitive deficit associated with rheumatic diseases: neuropsychological perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Sjogren's syndrome. Its contribution to neuropsychiatric syndrome in patients with primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Anti-Ro (SS-A) and anti-La (SS-B) in patients with Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus: clinicopathologic findings in thirteen cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Systemic lupus erythematosus with anti-Ro antibodies: clinical, histologic and immunologic findings. Report of three cases

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus and discoid lupus erythematosus. Comparative histopathologic findings

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus. Clinical, serologic, and immunogenetic studies of forty-nine patients seen in a nonreferral setting

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus. Clinical, serologic, immunogenetic, and therapeutic considerations in seventy-two patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Complement deficiency states

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

C4 null phenotypes among lupus erythematosus patients are predominantly the result of deletions covering C4 and closely linked 21-hydroxylase A genes.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Hereditary angioedema associated with subacute cutaneous lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Late onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Systemic lupus erythematosus in the elderly: clinical and immunological characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Frequency of systemic lupus erythematosus in different ethnic groups in hawaii

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The prevalence and incidence of systemic lupus erythematosus in Birmingham, England. Relationship to ethnicity and country of birth

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Annular erythema: a possible association with primary Sjögren's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Skin lesions associated with Sjögren's syndrome and anticytoplasmic antibodies in SLE patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Differences in clinical, serologic, and immunogenetic features of white versus Oriental anti-SS-A/Ro-positive patients

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Annular erythema associated with Sjögren's syndrome: a variant of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

HLA antigens in anti-Ro(SS-A)-positive patients with recurrent annular erythema

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Epidemiologic studies on systemic lupus erythematosus comparative data for new york city and jefferson county, alabama, 1956–1965

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Clinical features of systemic lupus erythematosus: differences related to race and age of onset

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Neonatal lupus syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

The neonatal lupus syndrome associated with U1RNP (nRNP) antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Ro and La antigens and maternal anti-La idiotype on the surface of myocardial fibres in congenital heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

A serological marker for neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Autoantibodies to SS-A/Ro in infants with congenital heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Placental transfer of anticytoplasmic antibodies in annular erythema of newborns

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Liver disease in association with neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Intrahepatic cholestasis in neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Neonatal lupus liver disease

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Neonatal lupus erythematosus in four successive siblings born to a mother with discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Pattern of cutaneous immunoglobulin G deposition in subacute cutaneous lupus erythematosus is reproduced by infusing purified anti-Ro (SSA) autoantibodies into human skin-grafted mice

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Clinical, histologic, and immunofluorescent distinctions between subacute cutaneous lupus erythematosus and discoid lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Cutaneous telangiectases in neonatal lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Autoantibody-associated congenital heart block: outcome in mothers and children

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Neonatal lupus erythematosus: dissolution of atrioventricular block after administration of corticosteroid to the pregnant mother

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Anti-SS-A antibodies and fetal outcome in maternal systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Neonatal lupus risk to newborns of mothers with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Ro (SS-A) antibody and antigen in a patient with congenital complete heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Neonatal lupus erythematosus. Report of serological and immunogenetic studies in twins discordant for congenital heart block

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Salmonella infection in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Anti-p57: a novel association with neonatal lupus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Sjöugren's syndrome influence of multiple hla-d region alloantigens on clinical and serologic expression

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

B-Lymphocyte Alloantigens Associated with Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Disease associations of the Ia-like human alloantigens. Contrasting patterns in rheumatoid arthritis and systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Relationships of HLA-DR and MT antigens to autoantibody expression in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Interrelationships of HLA-DR, MB, and MT phenotypes, autoantibody expression, and clinical features in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Gene interaction at HLA-DQ enhances autoantibody production in primary Sjögren's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Major histocompatibility complex haplotypes and complement C4 alleles in systemic lupus erythematosus. Results of a multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Clinical, serologic, and immunogenetic studies in childhood-onset systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Systemic lupus erythematosus exacerbated by piroxicam

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

A distinctive eruption in patients receiving oxprenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

Diltiazem and subacute cutaneous lupus erythematosus-like lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0190-9622%2896%2990315-1

7 January 2021

10.1016/S0190-9622(96)90315-1

Identifiers

DOI

1 reference

25 September 2017

1 reference